Treatment.com
Treatment.com (now Rocket Doctor AI Inc.) provides a proprietary, clinician-curated AI Global Library of Medicine and the Rocket Doctor virtual care platform, serving medical schools, pharmacists, physicians, payers, and underserved patients across North America and selected international markets.
- Company typePublic
- Founded2020
- HeadquartersVancouver, Canada
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Treatment.com does
Treatment.com AI Inc. (now rebranded Rocket Doctor AI Inc.; CSE: AIDR, OTC: AIRDF, FSE: 939) is a Vancouver-based healthcare technology company that builds AI-driven clinical decision support and virtual care infrastructure. Its core asset is the Global Library of Medicine (GLM), a proprietary, peer-reviewed repository of curated diagnostic content covering 1,000+ diseases and 10,000+ symptoms, deliberately positioned as an alternative to large language models. The GLM underpins multiple product layers: the Medical Education Suite (MES) used by medical schools including the University of Minnesota; the AI Pharmacy Assistant deployed in 50+ Canadian pharmacies; AI Patient and AI Doctor in Pocket point tools for students and clinicians; and, following the April 2025 acquisition of Rocket Doctor Inc., the integrated Rocket Doctor digital health platform (Starship EMR, RD Connect triage, RD Health Voyager) through which over 300 physicians deliver virtual and hybrid care across Canada and the U.S.
The company restructured in late 2023 from B2C to B2B, targeting enterprise customers including healthcare systems, medical schools, payers, and government programs. Revenue is generated through (1) insurance-billed virtual care delivered via Rocket Doctor (provincial health plans such as Alberta Health and Ontario OHIP, plus Medicaid/Medicare and managed-care contracts in Maryland, New York, and California); (2) subscription-based SaaS for MES products (AI Patient, AI Doctor in Pocket); (3) API/platform licensing of the GLM to enterprises and partners such as Novus Health and the aiXplain marketplace; and (4) transaction-fee economics through pharmacy-channel virtual care (75% of appointments result in prescriptions filled at the originating pharmacy). First reported revenue was CA$0.5M in Q2 2025 at an 89% gross margin. Distribution relies on direct enterprise sales, channel partners (pharmacy chains, municipal governments, insurance networks), and academic and clinical partnerships (Mayo Clinic, University of Minnesota, Melanoma Canada, EngageWell IPA, Health Cities/CAN Health Network).
The company has raised approximately CA$12.9M across private placements in 2024-2025 and a US$2M NIH Small Business Innovation grant in 2025. Cumulative operating scale disclosed in the input includes 700,000+ patient visits, 6.5M+ newly addressable U.S. beneficiaries through payer enrollment, and operational reach in Canadian provinces and multiple U.S. states plus exploration into China, the U.K., and Germany. Leadership includes CEO Dr. Essam Hamza, Rocket Doctor Inc. CEO Dr. William Cherniak, COO Richard Atkins (appointed May 2024), and CMO Dr. Kevin Peterson.
Treatment.com firmographics
Firmographics- Name
- Treatment.com
- Legal name
- Treatment.com AI Inc.
- Website
- https://treatment.com
- Company type
- Public
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Treatment.com (now Rocket Doctor AI Inc.) provides a proprietary, clinician-curated AI Global Library of Medicine and the Rocket Doctor virtual care platform, serving medical schools, pharmacists, physicians, payers, and underserved patients across North America and selected international markets.
- Ownership category
- akta.pro rank
Treatment.com industry classification
Industry- Product category
- Clinical Decision Support Software
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Diagnostic & Triage Decision Support (HLACAGAA)
Keywords
Where Treatment.com is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Treatment.com business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Education Suite (MES) Subscriptions: Monthly subscription-based SaaS solutions for medical students, residents, and healthcare professionals. AI Patient and AI Doctor in Pocket products offered on subscription basis.
- Digital Health Platform Services: Virtual care services delivered through Rocket Doctor platform, generating revenue from provincial health insurance (Alberta Health, Ontario OHIP), Medicaid, Medicare, and managed care plans.
- API/Platform Licensing: GLM platform licensed to healthcare enterprises, partners (Novus Health, aiXplain marketplace), and organizations requiring clinical information support.
- Pharmacy Program: Physician-led virtual care integrated into community pharmacies, generating appointments covered by provincial insurance. 75% of appointments result in prescriptions filled at originating pharmacy.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | AI Patient subscription |
| Subscription | Monthly | AI Doctor in a Pocket subscription |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
Treatment.com product offering
Product offeringCore offering
Treatment.com (operating as Rocket Doctor AI Inc.) develops AI-powered clinical decision support software, most notably the Global Library of Medicine (GLM), a proprietary curated medical knowledge platform used by healthcare professionals, medical schools, and pharmacy networks. The company also offers a Medical Education Suite, Starship EMR, and acquired the Rocket Doctor digital health platform that connects physicians with patients for virtual and hybrid care delivery.
Product overview
Treatment.com (now rebranded as Rocket Doctor AI Inc.) offers a platform-plus-modules architecture centered on its proprietary Global Library of Medicine (GLM). The GLM serves as the core AI knowledge engine providing clinical decision support across 1,000+ diseases and 10,000+ symptoms. Built on this foundation are multiple integrated modules: the Medical Education Suite (MES) for clinical skills training and assessment; AI Pharmacy Assistant for pharmacist decision support; and AI Patient/Doctor in Pocket for student and professional clinical assistance. Following the April 2025 acquisition of Rocket Doctor Inc., the portfolio expanded to include the Starship EMR (Provider and Patient portals), RD Connect triage solution, and RD Health Voyager. The company also operates virtual care stations and pharmacy-based programs. The platform leverages large language models alongside its curated GLM to deliver AI-powered clinical intelligence, with an API layer enabling third-party integrations.
Differentiator
Problem solved
Functional benefit
Brands
- Global Library of Medicine (GLM): Proprietary comprehensive AI-driven platform providing curated diagnostic medical information, covering over 1,000 diseases and 10,000+ symptoms and risk factors.
- Medical Education Suite (MES)
- AI Patient
- AI Doctor in a Pocket
- AI Pharmacy Assist
- Starship EMR
- RD Connect
- RD Health Voyager
- Rocket Doctor Inc.
Products and services
- Global Library of Medicine (GLM) Proprietary AI-powered clinical decision support platform that provides symptom assessment, differential diagnosis, and treatment recommendations for healthcare providers, insurers, and pharmacy networks.
- Medical Education Suite (MES) Digital medical education platform providing students with clinical simulation, case studies, and learning tools powered by the GLM knowledge base.
- Rocket Doctor Digital Health Platform Technology-driven digital health platform that empowers physicians to build and manage virtual or hybrid practices, connecting them with patients for telehealth consultations.
- Starship EMR Electronic Medical Records (EMR) system designed for healthcare providers with integrated clinical decision support.
- RD Connect Autonomous agent platform for care navigation, enabling insurance providers and health systems to guide patients through healthcare journeys using AI.
- RD Health Voyager Generative AI-powered health assistance tool that provides personalized health guidance to patients and providers.
- Virtual Care Stations Physical kiosks or stations deployed in underserved communities that connect patients remotely with physicians for consultations.
- AI Pharmacy Assistant AI-powered assistant for pharmacies that provides clinical decision support and medication guidance.
Quantifiable outcome
- 92%+ first diagnosis accuracy on medical clinical exams
- +5 more outcomes
Companies that use Treatment.com
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles5 records
Treatment.com technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability13 records
Feature7 records
Treatment.com partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and strategic.
- Health Cities and CAN Health NetworkcorePartnership to advance AI-powered clinical decision support in Alberta. Collaboration with Health Cities and CAN Health Network to expand healthcare technology adoption.
- Remmie, Inc.strategicReseller agreement for Remmie 4 FDA-approved and Health Canada cleared USB smart otoscope. Rocket Doctor distributes devices in Canada with 20% discount for patients using unique codes. MOU signed September 12, 2025.
- EngageWell IPAcorePartnership on Healthy Aging Program funded by $1 million CVS Health Foundation grant. Offers virtual health screenings for adults 60+ in New York City including heart health, memory, cognitive function, and mental health assessments.
- Central California Alliance for HealthcoreVirtual care program enabling Medi-Cal managed care plan members (approximately 450,000) to access urgent, primary, and specialty care from Rocket Doctor's physician network.
- Larta Institute's Heal.LA AcceleratorstrategicRocket Doctor joined Larta Institute's 2025 Heal.LA Accelerator cohort to expand access to virtual care. Non-dilutive accelerator program supporting healthtech innovation.
- Melanoma CanadastrategicPartnership to expand access to follow-up care for high-risk skin cancer patients in Ontario, Alberta, and British Columbia, supporting earlier intervention and continuity of care.
- AiyibotongstrategicCollaboration to explore commercial opportunities for clinical decision support in China and Far East markets. Strategic exploration of market expansion into Asian healthcare sector.
- EngageWellcoreExpanded partnership with EngageWell to enhance care coordination. Collaboration to improve healthcare delivery for underserved populations.
- SPRYTstrategicPartnership to improve patient access to healthcare services. SPRYT collaboration to expand healthcare delivery options.
- University of EdinburghstrategicPartnership to transform long-term care services across the UK. Collaboration focused on healthcare innovation in the UK market.
- Novus HealthcorePartnership with Novus Health focuses on developing new solutions for health risk assessment and medical second opinions. Novus Health's expertise in health navigation combined with Treatment's GLM platform to create innovative approaches to critical areas of healthcare.
- Toronto Metropolitan UniversitystrategicFirst in Canada strategic partnership to support clinical education of medical learners on a digital health platform. University collaboration for medical education advancement.
- aiXplaincoreCollaboration to integrate the Global Library of Medicine (GLM) into aiXplain's dynamic AI marketplace, enhancing accessibility to a broader audience. Both parties intend to explore international opportunities and provide GLM in multiple languages.
- Rush River ResearchstrategicCollaboration with Minneapolis-based Rush River Research to develop AI approach for collecting family medical history that is culturally sensitive for African-American families. NIH-funded Phase 1 with Phase 2 grant proposal submitted.
Scale indicators15 records
Recent moves8 records
Expansion highlights6 records
Treatment.com competitors and assessment
Company assessmentEmerging players
- Abridge: AI medical scribe and clinical note-generation platform - direct overlap with RD Health Voyager's patient history summarization and Treatment.com's clinical documentation AI capabilities.
Direct peers
- Babylon Health: AI-powered symptom triage and virtual primary care platform - closely comparable to the combined Rocket Doctor virtual care delivery and GLM/AI diagnostic decision support offering.
- Augmedix (Commure): AI clinical documentation platform embedded in physician workflows - comparable to RD Health Voyager's LLM-based chart summarization and Treatment.com's broader clinical AI documentation thesis.
- Suki AI: AI-powered clinical assistant and ambient scribe for physicians - comparable to Treatment.com's AI Doctor in a Pocket and GLM diagnostic decision support targeting healthcare professionals in clinical workflows.
- Ada Health: AI-driven symptom assessment and triage platform covering thousands of conditions - direct functional overlap with Treatment.com's GLM, RD Connect triage, and AI Patient virtual triage agents.
- Maven Clinic: Digital health platform combining AI-enabled triage with virtual clinician visits across specialty care - structurally similar to Rocket Doctor's marketplace model and Treatment.com's payer-sponsored virtual care positioning.
- K Health: AI-driven virtual primary care platform combining symptom assessment with clinician visits - directly comparable to Rocket Doctor's AI-triage-plus-physician virtual care model.
Broad incumbents
- Wolters Kluwer (UpToDate): Industry-leading evidence-based clinical decision support and drug reference platform (UpToDate) - the dominant incumbent in the same clinical decision support category Treatment.com's GLM targets.
- Amwell: Established telehealth platform serving health systems, payers, and employers - competes with Rocket Doctor for the same institutional virtual care contracts at significantly greater scale.
- Teladoc Health: Largest publicly-traded virtual care platform with broad enterprise payer and employer contracts - operates the same enterprise virtual care market Rocket Doctor targets, but at vastly greater scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Treatment.com social profiles
Digital presenceTreatment.com compliance and trust
Trust signalCompliance1 record
Treatment.com financial estimates
Financial estimateRevenue estimate
Valuation estimate
Treatment.com leadership team
Management profileNumber of profiles
Profiles4 records
Treatment.com subsidiaries and ownership
Company hierarchySubsidiaries3 records
Treatment.com funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Treatment.com M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Treatment.com
What does Treatment.com do?
Treatment.com (operating as Rocket Doctor AI Inc.) develops AI-powered clinical decision support software, most notably the Global Library of Medicine (GLM), a proprietary curated medical knowledge platform used by healthcare professionals, medical schools, and pharmacy networks. The company also offers a Medical Education Suite, Starship EMR, and acquired the Rocket Doctor digital health platform that connects physicians with patients for virtual and hybrid care delivery.
Is Treatment.com a public or private company?
Treatment.com is a public company. It is classified as public and is currently operating.
When was Treatment.com founded?
Treatment.com was founded in 2020. It employs 1 to 10 people.
Where is Treatment.com based?
Treatment.com is headquartered in Vancouver, Canada, in the North America region.
How does Treatment.com make money?
Four revenue lines are on record. Medical Education Suite (MES) Subscriptions are the primary driver. The others are digital Health Platform Services, API/Platform Licensing and pharmacy Program.
Who are Treatment.com's main competitors?
Abridge is listed as an emerging player. Direct peers are Babylon Health, Augmedix (Commure), Suki AI, Ada Health, Maven Clinic and K Health. Broad incumbents are Wolters Kluwer (UpToDate), Amwell and Teladoc Health.
Does Treatment.com have an API?
Yes. Treatment.com has developed an API layer enabling third-party integrations. The Global Library of Medicine (GLM) platform provides an API that enables integration with healthcare systems, electronic medical records, and enterprise partners. The API layer was completed from Q4 2023 through Q2 2025, with initial testing underway with internal businesses and pilot partners. Further refinements are scheduled through the second half of 2025. The GLM can be integrated behind enterprise firewalls for security and privacy. Developer documentation is at www.treatment.com.
What industry is Treatment.com in?
Treatment.com's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAGAA, Diagnostic & Triage Decision Support. Its SIC code is 7372.